No Agenda Show cover image

1788 - "chatJCD"

No Agenda Show

00:00

Funding Dynamics and Vaccine Technology

This chapter explores the complex relationship between pharmaceutical companies and taxpayer funding, with a focus on companies like Pfizer and Moderna. It delves into the recent withdrawal of funding for mRNA technology, critiques of media coverage, and the evolution of vaccine technologies from traditional methods to modern approaches. Additionally, it addresses the challenges of vaccine hesitancy and the importance of maintaining high vaccination rates to ensure community immunity.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app